SAFETUSSIN MAX STRENGTH MS

NDC 55505-230 · KRAMER LABORATORIES

Generic nameAcetaminophen, Dextromethorphan Hydrobromide, and Guaifenesin

Dosage formTABLET

RouteORAL

Active ingredient(s)ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN

Strength325; 10; 200 mg/1; mg/1; mg/1

Pharmacologic classDecreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]

Marketing categoryOTC MONOGRAPH DRUG

Packages

55505-230-24 — 24 TABLET in 1 CARTON (55505-230-24)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

55319-933 — ACETAMINOPHEN, DEXTROMETHORPHAN, PHENYLEPHRINE HCL, 55319-934 — ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL, 55319-954 — Acetaminophen Dextromethorphan HBr, 55319-960 — Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl, 55319-967 — Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl, 55319-968 — ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, 55319-970 — Acetaminophen, Aspirin, Caffeine, 55319-979 — Acetaminophen, Pamabrom, Pyrilamine Maleate, 55505-217 — Acetaminophen, Dextromethorphan Hydrobromide, and Guaifenesin, 55505-220 — Dextromethorphan Hydrobromide, and Guaifenesin, 55505-231 — Dextromethorphan Hydrobromide, and Guaifenesin, 55579-110 — ACETAMINOPHEN, 55579-405 — ACETAMINOPHEN, 55681-301 — GUAIFENESIN, 55681-311 — Guaifenesin 400 mg, 55700-991 — HYDROCODONE BITARTRATE AND ACETAMINOPHEN, 55700-992 — HYDROCODONE BITARTRATE AND ACETAMINOPHEN, 55758-012 — ACETAMINOPHEN, 55758-013 — DEXTROMETHORPHAN HBr and GUAIFENESIN, 55758-026 — ACETAMINOPHEN, +4838 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels